Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries

• Published in: Blood Vol. 117; no. 26; pp. 7121 - 7125
• Main Authors: Cogle, Christopher R., Craig, Benjamin M., Rollison, Dana E., List, Alan F.
• Format: Journal Article
• Language: English
• Published: Washington, DC Elsevier Inc 30.06.2011; Americain Society of Hematology; American Society of Hematology
• Subjects: Aged; Aged, 80 and over; Algorithms; Bias; Biological and medical sciences; Blood Cell Count - economics; Bone Marrow Examination - economics; Clinical Trials and Observations; Databases, Factual; Diagnostic Services - economics; Epidemiologic Methods; Female; Guidelines as Topic; Hematologic and hematopoietic diseases; Humans; Incidence; Insurance, Health, Reimbursement - statistics & numerical data; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Male; Medical sciences; Medicare; Myelodysplastic Syndromes - economics; Myelodysplastic Syndromes - epidemiology; Myeloid Neoplasia; Registries; SEER Program; United States - epidemiology; United States; Hematology; Register; Malignant hemopathy; Algorithm; Epidemiology; Myelodysplastic syndrome; Cancer; Incidence

The myelodysplastic syndromes (MDSs) are hematologically diverse hematopoietic stem cell malignancies primarily affecting older individuals. The incidence of MDS in the United States is estimated at 3.3 per 100 000; however, evidence suggests underreporting of MDS to centralized cancer registries. C...